Background-A long time goal of the medical research community has been
the identification of a reliable and valid marker for Crohn's disease
. Aim-To identify differences in the genetic expression patterns of he
althy and diseased tissues. Method-The RNA arbitrarily primed polymera
se chain reaction (RAP-PCR) procedure was modified to improve its pote
ntial to identify clinical markers in heterogeneous RNA populations. R
esults-With this procedure, a 1065 bp PCR product associated with the
inflammation that occurs in Crohn's disease was identified, cloned and
sequenced. Northern blot hybridisations showed that this novel sequen
ce originates from a unique RNA species of 3.1 kb. Dot blot hybridisat
ions clearly showed that this RNA species was specific to Crohn's dise
ase. Moreover, its abundance seemed to correlate with the severity of
inflammation. Finally, this RNA species was also detected in macroscop
ically normal areas from Crohn's disease specimens, suggesting that it
appears either early during the disease or at least before severe man
ifestations. Conclusion-This finding of a 3.1 kb RNA species permits t
he discrimination of Crohn's disease manifestations. Although further
clinical work is required, this transcript appears to have definite po
tential as a diagnostic marker.